pentosan polysulfate
Selected indexed studies
- Pentosan polysulfate maculopathy. (Surv Ophthalmol, 2022) [PMID:34000253]
- Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020. (Urology, 2021) [PMID:33045286]
- Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation? (Can J Urol, 2023) [PMID:38104330]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Pentosan polysulfate maculopathy. (2022) pubmed
- Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020. (2021) pubmed
- Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation? (2023) pubmed
- Pentosan polysulfate maculopathy: clinical considerations, pathobiology, and causality. (2025) pubmed
- Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease. (2025) pubmed
- Pentosan Polysulfate, a Semisynthetic Heparinoid Disease-Modifying Osteoarthritic Drug with Roles in Intervertebral Disc Repair Biology Emulating the Stem Cell Instructive and Tissue Reparative Properties of Heparan Sulfate. (2022) pubmed
- Pentosan polysulfate-induced thrombocytopenia and thrombosis. (1994) pubmed
- Update on maculopathy secondary to pentosan polysulfate toxicity. (2021) pubmed
- Microperimetry Findings in Pentosan Polysulfate Maculopathy. (2023) pubmed
- Pentosan Polysulfate Maculopathy-We Need to Know More. (2023) pubmed